FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
Published: 10/21/2021
Sources:
- Food and Drug Administration
Relevant To:
- All Healthcare Organizations
The U.S. Food and Drug Administration (FDA) is expanding the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:
- The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
- 65 years of age and older
- 18 through 64 years of a…